Larry Mattheakis - AnnexonInc Ex Officer

ANNX Stock  USD 4.96  0.26  5.53%   

Insider

Larry Mattheakis is Ex Officer of AnnexonInc
Age 67
Address 1400 Sierra Point Parkway, Brisbane, CA, United States, 94005
Phone650 822 5500
Webhttps://www.annexonbio.com

AnnexonInc Management Efficiency

The company has return on total asset (ROA) of (0.286) % which means that it has lost $0.286 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.506) %, meaning that it created substantial loss on money invested by shareholders. AnnexonInc's management efficiency ratios could be used to measure how well AnnexonInc manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.47 in 2024. Return On Capital Employed is likely to drop to -0.54 in 2024. At this time, AnnexonInc's Net Tangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 1.3 M in 2024, whereas Total Assets are likely to drop slightly above 209.3 M in 2024.
The company currently holds 31.36 M in liabilities with Debt to Equity (D/E) ratio of 0.2, which may suggest the company is not taking enough advantage from borrowing. AnnexonInc has a current ratio of 8.77, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist AnnexonInc until it has trouble settling it off, either with new capital or with free cash flow. So, AnnexonInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AnnexonInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AnnexonInc to invest in growth at high rates of return. When we think about AnnexonInc's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Chengwei YiMicroAlgo
48
Qiyong LiuTranscode Therapeutics
60
Jasna PenichMalaga Financial
65
John TellenbachMalaga Financial
56
Thomas CPAAmericold Realty Trust
64
Pamela KohnAmericold Realty Trust
56
MBA JDCardio Diagnostics Holdings
60
Donald LeeMalaga Financial
N/A
Leslie WojcikSEI Investments
N/A
Khara JulienAmericold Realty Trust
41
Robert BassAmericold Realty Trust
50
David IwasakaMalaga Financial
N/A
Mark BustamanteMalaga Financial
N/A
James SmigielSEI Investments
55
Shiwen LiuMicroAlgo
42
Li HeMicroAlgo
37
Joe McCabeSEI Investments
N/A
Timur DoganCardio Diagnostics Holdings
36
Randy BowersMalaga Financial
73
Jerry DonahueMalaga Financial
85
Robert ChambersAmericold Realty Trust
40
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company was incorporated in 2011 and is headquartered in Brisbane, California. Annexon operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people. AnnexonInc (ANNX) is traded on NASDAQ Exchange in USA. It is located in 1400 Sierra Point Parkway, Brisbane, CA, United States, 94005 and employs 70 people. AnnexonInc is listed under Biotechnology category by Fama And French industry classification.

Management Performance

AnnexonInc Leadership Team

Elected by the shareholders, the AnnexonInc's board of directors comprises two types of representatives: AnnexonInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AnnexonInc. The board's role is to monitor AnnexonInc's management team and ensure that shareholders' interests are well served. AnnexonInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AnnexonInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Esq JD, Pres CEO
Larry Mattheakis, Ex Officer
Arnon Rosenthal, Founder
Jennifer Lew, Ex CFO
Michael MBA, Executive Officer
Mirella Toro, Sec
JD Esq, President CEO
Ted Yednock, Chief VP
HenkAndre MD, Senior Medicine
Miriam Mason, Senior Communications
Jamie MD, Executive Officer
Dean Artis, Chief VP

AnnexonInc Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AnnexonInc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether AnnexonInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AnnexonInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Annexoninc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Annexoninc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnnexonInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy AnnexonInc Stock please use our How to Invest in AnnexonInc guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for AnnexonInc Stock analysis

When running AnnexonInc's price analysis, check to measure AnnexonInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnnexonInc is operating at the current time. Most of AnnexonInc's value examination focuses on studying past and present price action to predict the probability of AnnexonInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnnexonInc's price. Additionally, you may evaluate how the addition of AnnexonInc to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is AnnexonInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AnnexonInc. If investors know AnnexonInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AnnexonInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.46)
Return On Assets
(0.29)
Return On Equity
(0.51)
The market value of AnnexonInc is measured differently than its book value, which is the value of AnnexonInc that is recorded on the company's balance sheet. Investors also form their own opinion of AnnexonInc's value that differs from its market value or its book value, called intrinsic value, which is AnnexonInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AnnexonInc's market value can be influenced by many factors that don't directly affect AnnexonInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AnnexonInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if AnnexonInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnnexonInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.